Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Uro Gen Pharma Ltd. Names Chris Degnan As Chief Financial Officer

PUBLIC · URGNOct 09, 2024•over 1 year ago

Position

Chief Financial Officer

Company

UroGen Pharma

Chris Degnan

PrincetonBiotechnologyHealthcare

Description

UroGen Pharma Ltd. announced the appointment of Chris Degnan as Chief Financial Officer, succeeding Don Kim who is leaving to pursue other opportunities. The company expresses gratitude to Don Kim for his dedication and welcomes Chris Degnan to the leadership team.

Company Information

Company

UroGen Pharma

Location

400 Alexander Park Drive

Princeton, New Jersey, United States

About

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for UroGen Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months